Recent TNXP News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2024 02:10:11 PM
- Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals • GlobeNewswire Inc. • 11/13/2024 02:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 10:10:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 01:05:29 PM
- Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights • GlobeNewswire Inc. • 11/12/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2024 10:15:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 12:30:21 PM
- Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya • GlobeNewswire Inc. • 11/04/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 11:05:20 AM
- Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024 • GlobeNewswire Inc. • 11/01/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 08:30:37 PM
- Tonix Pharmaceuticals to Present at BIO-Europe® 2024 • GlobeNewswire Inc. • 10/29/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2024 09:16:22 PM
- Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference • GlobeNewswire Inc. • 10/25/2024 12:00:00 PM
- Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024 • GlobeNewswire Inc. • 10/24/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 12:05:14 PM
- Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA) • GlobeNewswire Inc. • 10/17/2024 12:00:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/16/2024 01:01:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 12:05:35 PM
- Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA) • GlobeNewswire Inc. • 10/16/2024 12:00:00 PM
- Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals • GlobeNewswire Inc. • 10/08/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 11:05:22 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/01/2024 04:15:07 AM
- Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAI • GlobeNewswire Inc. • 09/30/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 11:05:27 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM